Home World News FDA grants accelerated approval to iberdomide with daratumumab and hyaluronidase-fihj and dexamethasone...

FDA grants accelerated approval to iberdomide with daratumumab and hyaluronidase-fihj and dexamethasone for multiple myeloma

October 7, 2026

257

Evidence for efficacy is based on the results from the EXCALIBER-RRMM study